Citi names top life science tools and diagnostics stocks for the second half of 2026

au.investing.com

Citi analysts are cautiously optimistic about the Life Science Tools & Diagnostics sector's recovery in the second half of 2026. Citi's top picks include WAT, WST, GH, and CRL, citing strengths in their respective markets and resilience against AI disruption. The sector is seeing a gradual positive sentiment shift regarding AI's potential to accelerate drug development and R&D.


With a significance score of 0.9, this news ranks in the top 77% of today's 32558 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Citi names top life science tools and diagnostics stocks for the second half of 2026 | News Minimalist